000 01605 a2200445 4500
005 20250517094208.0
264 0 _c20180112
008 201801s 0 0 eng d
022 _a1095-9327
024 7 _a10.1016/j.mcn.2016.05.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Heng
245 0 0 _aROCK inhibitor abolishes the antibody response in experimental autoimmune myasthenia gravis.
_h[electronic resource]
260 _bMolecular and cellular neurosciences
_c07 2016
300 _a106-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
_xanalogs & derivatives
650 0 4 _aAnimals
650 0 4 _aAutoimmunity
_xdrug effects
650 0 4 _aB-Lymphocytes
_xdrug effects
650 0 4 _aFemale
650 0 4 _aGerminal Center
_xcytology
650 0 4 _aMyasthenia Gravis, Autoimmune, Experimental
_xtherapy
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Lew
650 0 4 _aT-Lymphocytes, Helper-Inducer
_xdrug effects
650 0 4 _arho-Associated Kinases
_xantagonists & inhibitors
700 1 _aZhang, Min
700 1 _aWang, Cong-Cong
700 1 _aLi, Xiao-Li
700 1 _aZhang, Peng
700 1 _aYue, Long-Tao
700 1 _aMiao, Shuai
700 1 _aDou, Ying-Chun
700 1 _aLi, Yan-Bin
700 1 _aDuan, Rui-Sheng
773 0 _tMolecular and cellular neurosciences
_gvol. 74
_gp. 106-13
856 4 0 _uhttps://doi.org/10.1016/j.mcn.2016.05.001
_zAvailable from publisher's website
999 _c26009853
_d26009853